Umesawa Mitsumasa, Yamagishi Kazumasa, Noda Hiroyuki, Ikeda Ai, Sawachi Shinobu, Muraki Isao, Chei Choy-Lye, Cui Renzhe, Nagao Masanori, Ohira Tetsuya, Sankai Tomoko, Tanigawa Takeshi, Kitamura Akihiko, Kiyama Masahiko, Iso Hiroyasu
Department of Public Health, Dokkyo Medical University, School of Medicine, 880 Kita-kobayashi, Mibu, Shimotsuga-gun, Tochigi, 321-0293, Japan.
Department of Public Health Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
BMC Cardiovasc Disord. 2016 Mar 5;16:55. doi: 10.1186/s12872-016-0219-1.
Although several cross-sectional and intervention studies showed that sodium intake or excretion was associated with blood pressure levels, no prospective study has examined the long-term association between sodium excretion in spot urine and blood pressure changes.
We conducted a prospective study of 889 normotensive subjects (295 men and 594 women, mean age 57.3 years) who underwent the baseline survey including spot urine test in 2005 and the follow-up survey in 2009 to 2011 (mean follow-up period: 5.8 years). We examined the association between sodium concentration in spot urine, a validated index of sodium excretion occurring over 24-h, and blood pressure changes between baseline and follow-up survey in all, non-overweight (body mass index(BMI) ≤ 25 kg/m(2)) and overweight normotensives.
For all subjects, sodium concentrations in spot urine were not associated with either systolic or diastolic blood pressure changes. When stratified by BMI at baseline survey, sodium concentrations were positively associated with systolic blood pressure changes in non-overweight subjects, but not in overweight subjects. After adjustment for age, sex, BMI, alcohol intake status, current smoking and estimated glomerular filtration rate, the multivariable-adjusted mean values of the systolic blood pressure change among non-overweight subjects was +7.3 mmHg in the highest quartiles of sodium concentrations, while it was +3.9 mmHg in the lowest quartile (P for difference = 0.021, P for trend = 0.040). After further adjustment of baseline blood pressure levels, the association was slightly weakened; the multivariable-adjusted mean values of the systolic blood pressure changes were +7.0 mmHg and +4.2 mmHg (P for difference = 0.047, P for trend = 0.071).
High sodium concentrations in spot urine were associated with subsequent systolic blood pressure increases among non-overweight normotensive individuals. (272 words).
尽管多项横断面研究和干预性研究表明,钠摄入或排泄与血压水平相关,但尚无前瞻性研究探讨随意尿钠排泄与血压变化之间的长期关联。
我们对889名血压正常的受试者(295名男性和594名女性,平均年龄57.3岁)进行了一项前瞻性研究,这些受试者在2005年接受了包括随意尿检测在内的基线调查,并于2009年至2011年接受了随访调查(平均随访期:5.8年)。我们研究了随意尿钠浓度(24小时钠排泄的有效指标)与所有、非超重(体重指数(BMI)≤25kg/m²)和超重血压正常者在基线和随访调查之间的血压变化之间的关联。
对于所有受试者,随意尿钠浓度与收缩压或舒张压变化均无关联。根据基线调查时的BMI进行分层后,钠浓度与非超重受试者的收缩压变化呈正相关,但与超重受试者无关。在调整年龄、性别、BMI、饮酒状况、当前吸烟情况和估计肾小球滤过率后,非超重受试者中,钠浓度最高四分位数组的收缩压变化多变量调整后平均值为+7.3mmHg,而最低四分位数组为+3.9mmHg(差异P=0.021,趋势P=0.040)。在进一步调整基线血压水平后,这种关联略有减弱;收缩压变化的多变量调整后平均值分别为+7.0mmHg和+4.2mmHg(差异P=0.047,趋势P=0.071)。
随意尿钠浓度高与非超重血压正常个体随后的收缩压升高有关。(272字)